Janssen satellite symposium: When innovation meets patients' needs in Multiple Myeloma and Amyloidosis


4.15PM CET:
Welcome and introduction - Hareth Nahi


4.20PM CET:
Current considerations for frontline therapy in MM - Jesús San Miguel 


4.40PM CET:
Redefining the treatment paradigm in relapsed and refractory MM in the era of immunotherapy - Meletions Dimopoulos


Panel discussion - all


5.10PM CET:
Patient and physician perspectives on recent advances in treatment for multiple myeloma - Yelak Biru & Francesca Gay


5.30PM CET:
Where will newer agents fit in the evolution of myeloma management? - Hermann Einsele


5.45PM CET:

Current management and future options in amyloidosis - Ashutosh Wechalekar


6.00PM CET:
Panel discussion - all


6.10PM CET:
Summary and close - Jesús San Miguel